L1CAM and ovarian carcinoma: In human patients with uterine and ovarian carcinomas, or pancreatic ductal adenocarcinoma, aberrant L1CAM expression was observed and accompanied by aggressive phenotype and tumor stages, making L1CAM a potential indicator of poor prognosis [32,33].